ORPIANESI, EMANUELA
ORPIANESI, EMANUELA
Dipartimento di Scienze della Salute
Anti-EGFR antibody reduces lung nodules by inhibition of EGFR-pathway in a model of lymphangioleiomyomatosis
2015-01-01 E. Lesma, E. Chiaramonte, S. Ancona, E. Orpianesi, A.M. Di Giulio, A. Gorio
Characterization of human TSC2 cells derived from a TSC/LAM patient chylous effusion
2011-09-01 E. Lesma, S. Ancona, V. Grande, S.M. Sirchia, E. Orpianesi, E. Chiaramonte, A.M. Di Giulio, A. Gorio
Chromatin remodelling by rosuvastatin normalizes TSC2-/meth cell phenotype through the expression of tuberin
2013-05-01 E. Lesma, S. Ancona, E. Orpianesi, V. Grande, A.M. Di Giulio, A. Gorio
Development of a cutaneous mouse model of TSC and LAM by injection of human tuberin-deficient cells : effects of chromatin remodelling agents
2013-10-26 E. Lesma, C. Bernardelli, E. Chiaramonte, S. Ancona, E. Orpianesi, A.M. Di Giulio, A. Gorio
Development of a lymphangioleiomyomatosis model by endonasal administration of human TSC2-/- smooth muscle cells in mice
2012-09-01 E. Lesma, E. Chiaramonte, E. Isaia, V. Grande, S. Ancona, E. Orpianesi, A.M. Di Giulio, A. Gorio
Differential modulation of matrix metalloproteinases-2 and-7 in LAM/TSC cells
2021-11-24 S. Ancona, E. Orpianesi, C. Bernardelli, E. Chiaramonte, R. Chiaramonte, S. Terraneo, F. Di Marco, E. Lesma
Direct and indirect pharmacological regulation of mTOR affects fate of LAM/TSC cells. Epithelial to mesenchymal transition features of LAM/TSC cells
2013-10-25 S. Ancona, E. Lesma, S.M. Sirchia, E. Orpianesi, A.M. Di Giulio, A. Gorio
Human LAM/TSC cells efficiently cause lung nodule formation and alveolar destruction. Pharmacological counteraction by modulation of mTOR activity
2013-10-25 E. Chiaramonte, E. Lesma, S. Ancona, E. Orpianesi, A.M. Di Giulio, A. Gorio
LAM/TSC CELLS BEARING A TSC2 MUTATION SECRETE CHEMOKINES AND MATRIXMETHALLOPROTEINASES
2012-09-01 E. Orpianesi, S. Ancona, V. Grande, E. Lesma, A.M. Di Giulio, A. Gorio
LAM/TSC cells cause pulmonary nodule development by endonasal administration in nude mice
2012-09-01 E. Chiaramonte, C. Bernardelli, S. Ancona, E. Orpianesi, E. Lesma, A.M. Di Giulio, A. Gorio
Matrix methalloproteinase 2 and 7 are new targets in LAM and TSC-related disorders
2013-10-25 E. Orpianesi, E. Lesma, S. Ancona, E. Chiaramonte, A.M. Di Giulio, A. Gorio
MOTILITY AND INVASIVE PROPERTIES OF LAM/TSC CELLS FROM CHYLOUS OF A LAM/TSC PATIENT
2012-09-01 S. Ancona, E. Lesma, E. Orpianesi, R. Chiaramonte, L. Mirandola, A.M. Di Giulio, A. Gorio
Role of chemokines in tuberous sclerosis and lymphangioleiomyomatosis
2011-09-01 E. Orpianesi
ROSUVASTATIN ACTING AS A DEMETHYLATING AGENT AFFECTS PROLIFERATION OF TSC2-/meth ASM CELLS
2012-09-01 V. Grande, E. Lesma, S. Ancona, E. Orpianesi, A.M. Di Giulio, A. Gorio
STUDIO DELLE CITOCHINE E DELLE METALLOPROTEASI NELLA LINFANGIOLEIOMIOMATOSI E NELLA SCLEROSI TUBEROSA
2014-01-30 E. Orpianesi
TSC2 epigenetic defect in primary LAM cells. Evidence of an anchorage-independent survival
2014-03-01 E. Lesma, S. Ancona, S.M. Sirchia, E. Orpianesi, V. Grande, P. Colapietro, E. Chiaramonte, A.M. Di Giulio, A. Gorio
Tuberin deficiency for an epigenetic modification in LAM cells from chylous of a TSC2 patient
2012-09-01 E. Lesma, S. Ancona, S.M. Sirchia, V. Grande, E. Orpianesi, R.M. Alfano, A.M. Di Giulio, A. Gorio